---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-044971"
form_type: "8-K"
ticker: "OVID"
cik: "0001636651"
company_name: "Ovid Therapeutics Inc."
filed_at: "2021-08-18T23:59:59+00:00"
generated_at: "2026-06-29T09:14:50.462493+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Ovid posts August 2021 corporate overview; no specific financial or operational updates provided in filing

## Summary
- Company posted corporate presentation to website but full content not included in filing text.
- No new financial guidance, clinical trial results, or business developments disclosed.
- Presentation likely covers pipeline, strategy, and forward-looking statements.
- Filing is a routine disclosure of a corporate overview; no specific numbers available.

## SEC filing metadata
- accession: 0001564590-21-044971
- form_type: 8-K
- ticker: OVID
- cik: 0001636651
- company_name: Ovid Therapeutics Inc.
- filed_at: 2021-08-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636651/000156459021044971/0001564590-21-044971-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636651/000156459021044971/ovid-8k_20210818.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-044971
- JSON: https://secwatch.observer/filing/0001564590-21-044971.json
- Plain text: https://secwatch.observer/filing/0001564590-21-044971.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.